December 31st, 2021


11 Health & Technologies Receives Funding from Crohn’s & Colitis Foundation IBD Ventures to Further Develop World’s First Digital Ostomy Wearable, The Remote Output Monitor.

Orange County, CA – 11 Health & Technologies Inc., a medical technology company with a proven technology to reduce complications in ostomy patients, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop 11 Health’s digitally connected Remote Output Monitor (ROM) to automatically track and monitor stoma patients’ output levels and provide alerts to patients of impending complications.

The ROM gathers stoma data for the patient and their medical team.

The ROM connects wirelessly to the 11 Health App. In the app, patients can review their personal data including risk of dehydration. In turn, the patient’s medical team is able to view the patient’s data through the 11 Health Clinical Dashboard – a HIPAA compliant, remote patient monitoring platform.

Patients with Inflammatory Bowel Disease (IBD) who undergo surgeries to create stoma are continuously at high risk of adverse events that may result in hospitalizations or emergency room visits. Ileostomies are associated with the second highest all-surgery 30-day readmission rates. 11 Health develops novel technologies that can be integrated into ostomy solutions to detect dehydration and reduce the prevalence, severity, and cost of complications in patients with Ileostomies.

The company has shown reductions of up to 80% in 30-day readmissions and 66% in 30-day Emergency Room visits.

Funding from IBD Ventures will support further development of the ROM. The next generation ROM will improve the overall accuracy of daily volume output to help predict and reduce dehydration related complications, achieve lower manufacturing costs to enable broader access to this unique technology solution, and produce even greater comfort and flexibility.

IBD Ventures was developed by the Crohn’s & Colitis Foundation to accelerate research and development of products that aim to improve the quality of life for patients with IBD. During 2021, less than 4% of applicants received funding, demonstrating the selectivity of the program.

“We are thrilled to receive this support from Crohn’s and Colitis Foundation’s IBD Ventures, demonstrating the Foundation’s support for the use of new technologies to improve patient outcomes.” said Bernhard Gilbey, CEO of 11 Health and Technologies. “It is vital for those Crohn’s and Colitis patients who live with a stoma to have access to the kind of technology that makes such a huge difference to their quality of life and which has such a marked effect on reducing the unnecessarily high complications that result from the current technology-free solutions.”

“As the first digital health investment of IBD Ventures, 11 Health’s technology is a cost-effective and patient-friendly approach to reducing post-operative complications – a major cause of morbidity and mortality among IBD patients,” said Gerard Honig, Director of Research Innovation for the Crohn’s & Colitis Foundation. “The Foundation is committed to accelerating the discovery and development of novel research-based solutions, selectively investing in products that can address an unmet need of IBD patients. We look forward to seeing the next generation ROM significantly improve both patient care management and overall patient outcomes in the near future.”

About the Crohn’s & Colitis Foundation

The Crohn’s & Colitis Foundation is a non-profit, volunteer-fueled organization dedicated to finding the cures for Crohn’s disease and ulcerative colitis, and to improving the quality of life of children and adults affected by these diseases. It was founded in 1967 by Irwin M. and Suzanne Rosenthal, William D. and Shelby Modell, and Henry D. Janowitz, M.D.

October 5th, 2021


11 Health and Technologies is excited to announce two new appointments to its board of directors.

Garrett Vygantas is a managing director at OSF Innovation, the venture arm of the OSF Health System Consortium and a board member at Inflammatix and Gauss Medical as well as an investor and adviser to numerous other healthcare technology companies.

Phil Christianson is CEO at Health Smart and has more than 30 years of experience leading divisions of Fortune 100 Companies and improving mid-sized companies providing healthplan administration services, disease management, SaaS and health information technology to health plan providers, health plans and employers.

Bernhard Gilbey, CEO at 11 Health and Technologies, commented that “These two appointments are a powerful validation of 11 Health’s potential. The complimentary skills that these two such highly regarded individuals bring to 11 Health will accelerate the Company’s success in helping ostomy patients improve their health outcomes and quality of life.”